Tag:
Curosurf
Latest Headlines
Latest Headlines
Chiesi grabs majority stake in Cornerstone
Italy's Chiesi Farmaceutici will buy a 51 percent stake in Cornerstone Therapeutics, a respiratory drug developer, in a deal valued at $70 million. Investors quickly signalled their disapproval of
